eF-site ID 3fjn-B
PDB Code 3fjn
Chain B

click to enlarge
Title The crystal structure of 17-alpha hydroxysteroid dehydrogenase Y224D mutant.
Classification OXIDOREDUCTASE
Compound Aldo-keto reductase family 1 member C21
Source null (AK1CL_MOUSE)
Sequence B:  SKCHCVILNDGNFIPVLGFGTALPLECPKSKAKELTKIAI
DAGFHHFDSASVYNTEDHVGEAIRSKIADGTVRREDIFYT
SKVWCTSLHPELVRASLERSLQKLQFDYVDLYLIHYPMAL
KPGEENFPVDEHGKLIFDRVDLCATWEAMEKCKDAGLTKS
IGVSNFNYRQLEMILNKPGLKYKPVCNQVECHPYLNQMKL
LDFCKSKDIVLVAYGVLGTQRDGGWVDQNSPVLLDEPVLG
SMAKKYNRTPALIALRYQLQRGIVVLNTSLKEERIKENMQ
VFEFQLSSEDMKVLDGLNRNMRYIPAAIFKGHPNWPFLDE
Y
Description


Functional site

1) chain B
residue 219
type
sequence L
description BINDING SITE FOR RESIDUE ACT B 701
source : AC3

2) chain B
residue 253
type
sequence A
description BINDING SITE FOR RESIDUE ACT B 701
source : AC3

3) chain B
residue 269
type
sequence N
description BINDING SITE FOR RESIDUE ACT B 701
source : AC3

4) chain B
residue 276
type
sequence R
description BINDING SITE FOR RESIDUE ACT B 701
source : AC3

5) chain B
residue 279
type
sequence E
description BINDING SITE FOR RESIDUE ACT B 701
source : AC3

6) chain B
residue 280
type
sequence N
description BINDING SITE FOR RESIDUE ACT B 701
source : AC3

7) chain B
residue 55
type
sequence Y
description BINDING SITE FOR RESIDUE ACT B 901
source : AC4

8) chain B
residue 117
type
sequence H
description BINDING SITE FOR RESIDUE ACT B 901
source : AC4

9) chain B
residue 118
type
sequence Y
description BINDING SITE FOR RESIDUE ACT B 901
source : AC4

10) chain B
residue 167
type
sequence N
description BINDING SITE FOR RESIDUE ACT B 901
source : AC4

11) chain B
residue 216
type
sequence Y
description BINDING SITE FOR RESIDUE ACT B 901
source : AC4

12) chain B
residue 55
type ACT_SITE
sequence Y
description Proton donor
source Swiss-Prot : SWS_FT_FI1

13) chain B
residue 84
type SITE
sequence K
description Lowers pKa of active site Tyr => ECO:0000250
source Swiss-Prot : SWS_FT_FI4

14) chain B
residue 190
type BINDING
sequence Q
description BINDING => ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17909281, ECO:0000269|PubMed:19237748
source Swiss-Prot : SWS_FT_FI2

15) chain B
residue 216
type BINDING
sequence Y
description BINDING => ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17909281, ECO:0000269|PubMed:19237748
source Swiss-Prot : SWS_FT_FI2

16) chain B
residue 270
type BINDING
sequence T
description BINDING => ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17909281, ECO:0000269|PubMed:19237748
source Swiss-Prot : SWS_FT_FI2

17) chain B
residue 20
type BINDING
sequence G
description BINDING => ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17909281, ECO:0000269|PubMed:19237748
source Swiss-Prot : SWS_FT_FI2

18) chain B
residue 50
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17909281, ECO:0000269|PubMed:19237748
source Swiss-Prot : SWS_FT_FI2

19) chain B
residue 166
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17909281, ECO:0000269|PubMed:19237748
source Swiss-Prot : SWS_FT_FI2

20) chain B
residue 31
type BINDING
sequence K
description
source Swiss-Prot : SWS_FT_FI3

21) chain B
residue 117
type BINDING
sequence H
description
source Swiss-Prot : SWS_FT_FI3


Display surface

Download
Links